Company Filing History:

3 out of 7

Enzo Life Sciences, Inc. C/o Enzo Biochem, Inc.

patents

Enzo Diagnostics, Inc.

patents

Years Active: 1991-2012

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8097405 - Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs (2012-01-17),

2. 7220854 - Sugar moiety labeled nucleotide, and an oligo- or polynucleotide, and other compositions comprising such sugar moiety labeled nucleotides (2007-05-22),

3. 7064197 - System, array and non-porous solid support comprising fixed or immobilized nucleic acids (2006-06-20),

4. 6992180 - Oligo- or polynucleotides comprising phosphate-moiety labeled nucleotides (2006-01-31),

5. 5260433 - Saccharide specific binding system labeled nucleotides (1993-11-09),

6. 5241060 - Base moiety-labeled detectable nucleatide (1993-08-31),

7. 4994373 - Method and structures employing chemically-labelled polynucleotide probes (1991-02-19),

Title: Innovator Spotlight: Dollie Kirtikar - A Pioneer in Nucleic Acid Sequencing

Introduction: Dollie Kirtikar, a renowned inventor based in Elmhurst, NY, has made significant contributions to the field of nucleic acid sequencing. With an impressive portfolio of 7 patents, Dollie has been at the forefront of developing innovative processes for nucleic acid detection and chromosomal characterization.

Latest Patents: Dollie's latest patents focus on nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs. These processes involve determining the sequence of nucleic acids by utilizing nucleotides that have been made detectable through various modifications. The applications extend to detecting the presence of nucleic acids of interest and characterizing chromosomal sequences.

Career Highlights: Dollie Kirtikar has worked with prestigious companies like Enzo Life Sciences, Inc. and Enzo Biochem, Inc. His expertise in nucleic acid sequencing has been instrumental in advancing diagnostic tools for detecting analytes and developing therapeutic agents. Dollie's innovative approach has paved the way for groundbreaking developments in the field.

Collaborations: Throughout his career, Dollie has collaborated with esteemed coworkers such as Jannis G Stavrianopoulos and Elazar S Rabbani. These collaborations have resulted in fruitful partnerships and the exchange of ideas that have enhanced the impact of Dollie's inventions in the scientific community.

Conclusion: Dollie Kirtikar's passion for innovation and dedication to advancing nucleic acid sequencing technologies have solidified his position as a pioneer in the field. His patents and collaborations stand as a testament to his profound impact on the scientific community, shaping the future of diagnostic tools and therapeutic advancements.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.